Cenexa Labs · Laboratory catalog
FOXO4-DRI
For laboratory research only. Not for human or animal use.
Research & sources ↓From $167.99 USD
Lowest listed one-time option, checked October 12, 2026. Options: 10mg. Package amounts, not use instructions. Confirm the selected option, price, availability, taxes and shipping with Cenexa.
Opens this exact product on Cenexa Labs. The supplier completes the sale.
Research reference
About FOXO4-DRI
A modified peptide associated with FOXO4/p53 and cellular-senescence research. Experimental model findings do not establish a longevity benefit in people.
How to read the evidence
The publications below concern their own experimental materials and settings. They do not verify this supplier’s batch, safety or suitability for personal use.
Sources and further reading
- FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway.
Frontiers in bioengineering and biotechnology · 2025 · PMID 41625068
- The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.
Nature communications · 2025 · PMID 40593617
- Cenexa product specifications and COA information — supplier source for the product identity, image, options and price.
Checked October 12, 2026. This is a reading guide, not a systematic review. No exact-commercial-product study has been verified for this listing.